Comparative Risk of Serious Infections with Biologic Agents and Oral Small Molecules in Inflammatory Bowel Diseases: 2026 Update.
- DOI
- 10.1053/j.gastro.2026.09.003
- Published
- 2026 Sep 17
- Container
- Gastroenterology
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1053/j.gastro.2026.09.003,
title = {Comparative Risk of Serious Infections with Biologic Agents and Oral Small Molecules in Inflammatory Bowel Diseases: 2026 Update.},
author = {Solitano V and Silverman A and Miyatani Y and Ahuja D and Jairath V and Singh S and IBD Pharmacoepidemiology Group},
year = {2026},
journal = {Gastroenterology},
doi = {10.1053/j.gastro.2026.09.003},
url = {https://doi.org/10.1053/j.gastro.2026.09.003}
}RIS
TY - JOUR TI - Comparative Risk of Serious Infections with Biologic Agents and Oral Small Molecules in Inflammatory Bowel Diseases: 2026 Update. AU - Solitano V AU - Silverman A AU - Miyatani Y AU - Ahuja D AU - Jairath V AU - Singh S AU - IBD Pharmacoepidemiology Group PY - 2026 JO - Gastroenterology DO - 10.1053/j.gastro.2026.09.003 UR - https://doi.org/10.1053/j.gastro.2026.09.003 ER -
APA
V, S., A, S., Y, M., D, A., V, J., S, S., & Group, I. P. (2026). Comparative Risk of Serious Infections with Biologic Agents and Oral Small Molecules in Inflammatory Bowel Diseases: 2026 Update.. Gastroenterology. https://doi.org/10.1053/j.gastro.2026.09.003
Source records
- pubmed · retrieved 2026-09-25T09:30:23.781Z